BIM
ASMB icon

Bogle Investment Management’s Assembly Biosciences ASMB Stock Holding History

Bogle Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,402
Closed -$4.02M – 309
2017
Q4 		$4.02M Buy
+7,402
New +$3.35M 0.3% 105
2015
Q3 		– Sell
-4,776
Closed -$1.1M – 362
2015
Q2 		$1.1M Buy
+4,776
New +$922K 0.08% 253

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bogle Investment Management's ASMB Position: Q1 2018 in Review

Bogle Investment Management sold out of Assembly Biosciences (ASMB) in Q1 2018, closing a stake of 7,402 shares — an estimated $4.02M sold.

Bogle Investment Management first reported a position in ASMB in Q2 2015 and held it in 2 quarters. The position peaked at $4.02M in Q4 2017. 107 funds tracked by Wall St. Rank hold ASMB as of Q1 2018.

  • Bogle Investment Management reported no remaining Assembly Biosciences position as of Q1 2018 after selling out during the quarter.
  • Bogle Investment Management sold 7,402 Assembly Biosciences shares in Q1 2018, an estimated $4.02M.
  • Bogle Investment Management first reported a position in Assembly Biosciences in Q2 2015 and held it in 2 quarters.
  • Bogle Investment Management's Assembly Biosciences position peaked at $4.02M in Q4 2017.
  • 107 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2018.

Based on Bogle Investment Management's 13F filing for Q1 2018, filed 14 May 2018.